Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/85.2
Name: Drug, bio-affecting and body treating compositions > Lymphokine > Interleukin
Description: Subject matter in which the immune mediator is a macrophage derived factor that promotes short term proliferation of T cells (IL1) or a lymphocyte derived factor that promotes long term proliferation of T cells in culture (IL2).

Patents under this class:

Patent Number Title Of Patent Date Issued
8709996 Pharmaceutical treatment process using chitosan or derivative thereof Apr. 29, 2014
8709464 Porous objects having immobilized encapsulated biomolecules Apr. 29, 2014
8703709 Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors Apr. 22, 2014
8703145 Materials and methods for immunizing against FIV infection Apr. 22, 2014
8691205 Mono- and di-PEG IL-10 production; and uses Apr. 8, 2014
8686154 Compounds and compositions for delivering active agents Apr. 1, 2014
8679471 Modulation of regulatory T cells by human IL-18 Mar. 25, 2014
8652457 Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection Feb. 18, 2014
8642026 Methods and compositions for contributing to the treatment of cancers Feb. 4, 2014
8642025 Hepatitis C virus inhibitors Feb. 4, 2014
8637567 Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid Jan. 28, 2014
8637469 Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors Jan. 28, 2014
8637029 Methods for the treatment of gout Jan. 28, 2014
8632801 Stable therapeutic formulations Jan. 21, 2014
8613914 Peptidomimetic sulfamide compounds and antiviral uses thereof Dec. 24, 2013
8603456 Method of treating hair loss with compositions containing interleukin-1 Dec. 10, 2013
8597958 IL1RL-1 as a cardiovascular disease marker and therapeutic target Dec. 3, 2013
8592364 CCR7 ligand delivery and co-delivery in immunotherapy Nov. 26, 2013
8586543 IL-8 biomarker for monitoring cancer treatment with certain ERK inhibitors Nov. 19, 2013
8580267 Immunocytokines for tumour therapy with chemotherapeutic agents Nov. 12, 2013
8575088 Method of preventing acute or sub-acute hepatic failure by administering a long-acting recombinant human soluble tumor necrosis factor alpha receptor II fusion protein Nov. 5, 2013
8574563 Hepatitis C virus inhibitors Nov. 5, 2013
8563040 Compositions and methods for forming and strengthening bone Oct. 22, 2013
8545830 Multi-functional polymeric materials and their uses Oct. 1, 2013
8540977 IL-11 muteins Sep. 24, 2013
8536128 Granulin/epithelin precursor (GEP), a chondrogenic growth factor and target in cartilage disorders Sep. 17, 2013
8529882 Peptidomimetic protease inhibitors Sep. 10, 2013
8518879 Skin cream Aug. 27, 2013
8512690 Derivatised proline containing peptide compounds as protease inhibitors Aug. 20, 2013
8492118 Fusion molecules and IL-15 variants Jul. 23, 2013
8491904 Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography Jul. 23, 2013
8486387 Modified two-component gelation systems, methods of use and methods of manufacture Jul. 16, 2013
8486386 Modified two-component gelation systems, methods of use and methods of manufacture Jul. 16, 2013
8486382 Method for treating cervical cancer Jul. 16, 2013
8481021 IL-1F5 polypeptides Jul. 9, 2013
8481003 Anti-CD74 immunoconjugates and methods Jul. 9, 2013
8476231 Conditioned cell culture medium compositions and methods of use Jul. 2, 2013
8475784 IL-21 variants Jul. 2, 2013
8470562 IRX-2 modified manufacturing process Jun. 25, 2013
8470307 Methods for treating acute myeloid leukemia with diphtheria toxin-interleukin-3 conjugates Jun. 25, 2013
8460647 Pre-ligand assembly domain of the IL-17 receptor Jun. 11, 2013
8455443 Methods of use of skin wound healing compositions Jun. 4, 2013
8449874 Interleukin-1 muteins linked to virus-like particles to treat IL-1 associated diseases May. 28, 2013
8445442 CCL18 and CCL3 methods and compositions for detecting and treating cancer May. 21, 2013
8445017 Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof May. 21, 2013
8440620 Methods, compositions and articles of manufacture for contributing to the treatment of cancers May. 14, 2013
8420087 Interleukin-12 targeted to oncofoetal fibronectin Apr. 16, 2013
8415456 Substituted IL-15 polypeptides Apr. 9, 2013
8414876 Methods of using IL-1 antagonists to treat autoinflammatory disease Apr. 9, 2013
8410082 Fluorinated diaryl urea derivatives Apr. 2, 2013

  Recently Added Patents
Transmission terminal, transmission system, transmission method, and recording medium storing transmission control program
Interposer having molded low CTE dielectric
Encoder that detects positional information of a moving body generating interference fringes that move in opposite directions
Cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives
Unsupervised document clustering using latent semantic density analysis
Visual model importation
Preparation and use of meristematic cells belonging to the Dendrobium phalaenopsis, Ansellia, Polyrrhiza, Vanilla, Cattleya and Vanda genera with high content of phenylpropanoids, hydrosoluble
  Randomly Featured Patents
Portable gas grill
Atomization device for a refrigerant
Preventing stains on multiple-electroplated articles
Cardiovascular protection using anti-aldosteronic progestins
Integrated hydromethanation fuel cell power generation
Integrated circuit package system including honeycomb molding
Slide frame for a warp knitting machine
Shielded stacking electrical connector assembly
Adaptor plate mounting system for marine jet propulsion unit
Electrostatic atomization device